As of 2024-09-09, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -2.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 61.28 mil USD. CTSO's TTM EBITDA according to its financial statements is -22.54 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 21.9x | 20.4x |
| Forward P/E multiples | 20.4x - 22.5x | 21.4x |
| Fair Price | (8.55) - (9.17) | (8.75) |
| Upside | -930.2% - -990.5% | -949.5% |
| Date | EV/EBITDA |
| 2024-09-06 | -2.72 |
| 2024-09-05 | -2.69 |
| 2024-09-04 | -2.62 |
| 2024-09-03 | -2.69 |
| 2024-08-30 | -2.77 |
| 2024-08-29 | -2.69 |
| 2024-08-28 | -2.67 |
| 2024-08-27 | -2.74 |
| 2024-08-26 | -2.82 |
| 2024-08-23 | -2.84 |
| 2024-08-22 | -2.74 |
| 2024-08-21 | -2.79 |
| 2024-08-20 | -2.77 |
| 2024-08-19 | -2.77 |
| 2024-08-16 | -2.74 |
| 2024-08-15 | -2.69 |
| 2024-08-14 | -2.60 |
| 2024-08-13 | -2.39 |
| 2024-08-12 | -2.38 |
| 2024-08-09 | -2.77 |
| 2024-08-08 | -2.74 |
| 2024-08-07 | -2.86 |
| 2024-08-06 | -2.67 |
| 2024-08-05 | -2.79 |
| 2024-08-02 | -3.13 |
| 2024-08-01 | -3.01 |
| 2024-07-31 | -3.13 |
| 2024-07-30 | -3.09 |
| 2024-07-29 | -3.15 |
| 2024-07-26 | -2.72 |
| 2024-07-25 | -2.72 |
| 2024-07-24 | -2.67 |
| 2024-07-23 | -2.71 |
| 2024-07-22 | -2.77 |
| 2024-07-19 | -2.77 |
| 2024-07-18 | -2.74 |
| 2024-07-17 | -2.89 |
| 2024-07-16 | -2.94 |
| 2024-07-15 | -2.82 |
| 2024-07-12 | -2.84 |
| 2024-07-11 | -2.58 |
| 2024-07-10 | -2.62 |
| 2024-07-09 | -2.67 |
| 2024-07-08 | -2.67 |
| 2024-07-05 | -2.43 |
| 2024-07-03 | -2.31 |
| 2024-07-02 | -2.22 |
| 2024-07-01 | -1.92 |
| 2024-06-28 | -1.93 |
| 2024-06-27 | -2.10 |